ML STRATEGIES, LLC for ASTELLAS PHARMA US, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 15, 2009 | $60,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jan 6, 2010 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 2313 and H.R. 3697, The Strategies to Address Antimicrobial Resistyance (STAAR Act); S. 2278, The Community and Healthcare Associated Infections (CHAI) Reduction Act; H. Res. 988 and S. Res. 454 MRSA Awareness Month. S. 3560, Q1 Program Suplemental Funding Act of 2008, provisions regarding antibiotics.
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID LEITER | — |
| JEREMY RABINOVITZ | Chief of Staff - Congresswoman Lois Capps |
Medicare/Medicaid MMM
Issues related to the implementation of Section 501 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, The Fair Medicaid Drug Payment Act, Section 2 (b) Prior Authorization Programs; S. 1887 and H.R. 3061 Amending Title XVIII of the Social Security Act to ensure access to critical medications under Medicare Part D.
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID LEITER | — |
| JEREMY RABINOVITZ | Chief of Staff - Congresswoman Lois Capps |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.